VIRIDIAN THERAPEUTICS INC (VRDN:NASDAQ)
$21.24 -1.05 (-4.7106%)
Analysed VIRIDIAN THERAPEUTICS INC (VRDN:NASDAQ) News Sources
VRDN Stock Jumps 6% After-Hours As Viridian Wins First FDA Approval
26-06-2026
stocktwits.com
Comcast, Viridian Therapeutics jump premarket; Doximity slips
29-06-2026
yahoo.com
Viridian Therapeutics' Lumvoa Could Start Generating More Meaningful Revenue in 2027, RBC Says
30-06-2026
yahoo.com
Wedbush Sees Commercial Edge for Viridian (VRDN) After FDA Milestone
06-07-2026
yahoo.com
Viridian Therapeutics (VRDN) Stock Still Looks Above Fair Value Today
15-07-2026
yahoo.com
Viridian Therapeutics (VRDN) Rebounds Sharply, Is The Valuation Still Too Rich?
15-07-2026
yahoo.com
Lumvoa’s Unique Profile Leads to Optimism Around Viridian Therapeutics (VRDN)
15-07-2026
yahoo.com
Viridian Therapeutics Highlights Recent Business Progress and Reports Second Quarter 2026 Financial Results
06-08-2026
yahoo.com
Viridian Therapeutics to See 'Minimal' Revenue Growth in H2, RBC Capital Markets Says
07-08-2026
yahoo.com
Viridian Therapeutics to Participate in the Wells Fargo 21st Annual Healthcare Conference
02-09-2026
yahoo.com
What is the current price of VIRIDIAN THERAPEUTICS INC (VRDN:NASDAQ)?
The current price of VIRIDIAN THERAPEUTICS INC (VRDN:NASDAQ) is $21.24.
VIRIDIAN THERAPEUTICS INC (VRDN:NASDAQ) absolute price change since previous trading day?
The absolute price change of VIRIDIAN THERAPEUTICS INC (VRDN:NASDAQ) since the previous trading day is $-1.05.
VIRIDIAN THERAPEUTICS INC (VRDN:NASDAQ) percentage price change since previous trading day?
The percentage price change of VIRIDIAN THERAPEUTICS INC (VRDN:NASDAQ) since the previous trading day is -4.7106%.
What is the most recent average sentiment score for VIRIDIAN THERAPEUTICS INC (VRDN:NASDAQ)?
The most recent average sentiment score for VIRIDIAN THERAPEUTICS INC (VRDN:NASDAQ) is 79 out of 100.
What is the most recent average sentiment for VIRIDIAN THERAPEUTICS INC (VRDN:NASDAQ)?
The most recent sentiment for VIRIDIAN THERAPEUTICS INC (VRDN:NASDAQ) is .
SEC-8K** Filing Available For VIRIDIAN THERAPEUTICS INC (VRDN:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.